SAN JOSE, Calif., April 30, 2018 -- The latest market report published by Credence Research, Inc. “North America Cystoscopes Market: Growth, Future Prospects, and Competitive Analysis, 2018 -2026” the North America cystoscopes market will be valued at US$ 207.2 Mn by 2026.
Market Insights
North America cystoscopes market valued at US$ 135.1 Mn in 2017 and exhibited steady growth with a CAGR of over 4% during the forecast period. Minimal invasion & shorter procedural time, increased research activities facilitating product precision and technological development in healthcare sector complimented with high disposable income catalyze the overall market growth. Additionally, growing prevalence of bladder cancer and kidney stones in North America has increased the demand for enhanced diagnostic techniques with minimal invasion. The American Cancer Society estimates that 81,190 new cases of urinary bladder cancer to be diagnosed in 2018 making bladder cancer as the fourth common cancer in the country; while the Canadian Cancer Society recorded 8,900 Canadians diagnosed with bladder cancer in year 2017. As per an article by Justin B. Ziemba and Brian R. Matlaga published in 2017 (Epidemiology and economics of nephrolithiasis; Investig Clin Urol. 2017 Sep; 58(5): 299–306.), nephrolithiasis (kidney stones) was prevalent in 10.6% of men and 7.1% of women in the U.S. Advent of new techniques such as Blue Light Cystoscopy (BLC) with Cysview has enhanced the diagnosis of bladder cancer thus increasing the demand for cystoscopes. Rising adoption of BLC technique by industrial players namely, Karl Storz GmbH & Co. KG and Olympus Corporation further contributes to the lucrativeness of this market.
Based on product types, video cystoscopes and non-video cystoscopes form the cystoscopes market, wherein video cystoscopes held largest market share in 2017. Lack of patient discomfort and enhanced diagnostic & imaging features will increase the demand for video cystoscopes during the during the forecast period from 2018 to 2026. However, the demand for non-video cystoscopes shall continue in the market, particularly in clinics and cost-sensitive end-users in the market. Of the end-users analyzed (hospitals, ambulatory care services and clinics), hospitals dominated the market in 2017 and expected to continue this trend throughout the forecast period from 2016 to 2026.
The countries analyzed in North America market are U.S. and Canada, of which U.S dominated the North America cystoscopes market while Canada exhibited fastest CAGR during the forecast period. The supremacy of U.S. is due to increased availability of cystoscopy techniques, skilled professionals, growing prevalence of bladder cancer and structured reimbursement policies.
Various market leaders contribute to the strong position of North America cystoscopes market growth. Some of such players include Cogentix Medical, Inc., Fujifilm Corporation, Karl Storz GmbH & Co. KG, Laborie Medical Technologies, Inc., Olympus Corporation, PENTAX Medical Company, Richard Wolf GmbH, and Stryker Corporation.
Key Market Movements:
- North America cystoscopes market witnessed steady growth with a CAGR of over 4% during the forecast period from 2018 to 2026
- Rising prevalence of bladder cancer & kidney stone coupled with growing awareness of cystoscopy ensures lucrativeness to this market
- Hospitals dominated the market in 2017 owing to availability of skilled professionals and higher patient trust on hospital procedures
- Growing demand for video cystoscopes owing to its cost efficiency and enhanced diagnostic benefits catalyzes the overall North America cystoscopes market
Browse Full Report With TOC, Figures And Tables @ http://www.credenceresearch.com/report/north-america-cystoscopes-market
Related Reports:
Medical Tapes & Bandages Market
Venous Thromboembolism (VTE) Treatment Market
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
E-mail: [email protected]
Ph: +1-800-361-8290
Connect With US:
Web: Credence Research
Facebook @ https://www.facebook.com/CredenceResearch
Twitter @ https://twitter.com/CredenceResearc
Linkedin @ https://us.linkedin.com/company/credenceresearch
G+ @ https://plus.google.com/+Credenceresearch


Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
World game at war: why some European nations have threatened a World Cup boycott 



